Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America In Situ Hybridization Market, by Technology
1.4.2 North America In Situ Hybridization Market, by End Use
1.4.3 North America In Situ Hybridization Market, by Application
1.4.4 North America In Situ Hybridization Market, by Product
1.4.5 North America In Situ Hybridization Market, by Probe
1.4.6 North America In Situ Hybridization Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America In Situ Hybridization Market by Technology
3.1 North America Fluorescent In Situ Hybridization (FISH) Market by Country
3.2 North America Chromogenic In Situ Hybridization (CISH) Market by Country
Chapter 4. North America In Situ Hybridization Market by End-use
4.1 North America Research & Diagnostic Laboratories Market by Country
4.2 North America Academic Institutes Market by Country
4.3 North America CROs Market by Country
4.4 North America Others Market by Country
Chapter 5. North America In Situ Hybridization Market by Application
5.1 North America Cancer Market by Country
5.2 North America Cytogenetics Market by Country
5.3 North America Developmental Biology Market by Country
5.4 North America Infectious Diseases Market by Country
5.5 North America Others Market by Country
Chapter 6. North America In Situ Hybridization Market by Product
6.1 North America Instruments Market by Country
6.2 North America Kits & Probes Market by Country
6.3 North America Software Market by Country
6.4 North America Services Market by Country
Chapter 7. North America In Situ Hybridization Market by Probe
7.1 North America DNA Market by Country
7.2 North America RNA Market by Country
Chapter 8. North America In Situ Hybridization Market by Country
8.1 US In Situ Hybridization Market
8.1.1 US In Situ Hybridization Market by Technology
8.1.2 US In Situ Hybridization Market by End-use
8.1.3 US In Situ Hybridization Market by Application
8.1.4 US In Situ Hybridization Market by Product
8.1.5 US In Situ Hybridization Market by Probe
8.2 Canada In Situ Hybridization Market
8.2.1 Canada In Situ Hybridization Market by Technology
8.2.2 Canada In Situ Hybridization Market by End-use
8.2.3 Canada In Situ Hybridization Market by Application
8.2.4 Canada In Situ Hybridization Market by Product
8.2.5 Canada In Situ Hybridization Market by Probe
8.3 Mexico In Situ Hybridization Market
8.3.1 Mexico In Situ Hybridization Market by Technology
8.3.2 Mexico In Situ Hybridization Market by End-use
8.3.3 Mexico In Situ Hybridization Market by Application
8.3.4 Mexico In Situ Hybridization Market by Product
8.3.5 Mexico In Situ Hybridization Market by Probe
8.4 Rest of North America In Situ Hybridization Market
8.4.1 Rest of North America In Situ Hybridization Market by Technology
8.4.2 Rest of North America In Situ Hybridization Market by End-use
8.4.3 Rest of North America In Situ Hybridization Market by Application
8.4.4 Rest of North America In Situ Hybridization Market by Product
8.4.5 Rest of North America In Situ Hybridization Market by Probe
Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.2 Abbott Laboratories
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 SWOT Analysis
9.3 PerkinElmer, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Agilent Technologies, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.5 Merck Group
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.6 Bio-Rad laboratories, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expenses
9.7 Bio-Techne Corporation (Advanced Cell Diagnostics, Inc.)
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.8 Danaher Corporation (Leica Biosystems)
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Partnerships, Collaborations, and Agreements:
9.9 F. Hoffmann-La Roche Ltd.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.10. Neogenomics, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental Analysis
9.10.4 Research & Development Expenses
Unique Offerings 